Literature DB >> 31802108

Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors.

Sam Sadigh1, Sahar J Farahani1, Abhishek Shah1, David Vaughn2, Priti Lal1.   

Abstract

OBJECTIVES: To characterize the tumor microenvironment of testicular germ cell tumors (GCTs) using immunohistochemical markers.
METHODS: Seventy-seven orchiectomies, including 36 nonmetastatic (NM) seminomas, 15 metastatic (M) seminomas, 13 nonmetastatic nonseminomatous germ cell tumors (NSGCTs), and 13 metastatic NSGCTs, were studied with PD-1, PD-L1, FOXP3, CD68, CD163, and mismatch repair (MMR) immunohistochemistry. FOXP3+ and PD-1+ tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) expressing CD68 and CD163 were enumerated. PDL-1 expression was evaluated on tumor cells and macrophages.
RESULTS: GCTs primarily express PD-L1 on TAMs, except choriocarcinoma, where true tumor cell positivity was noted. Seminomas reveal increased intratumoral PD-L1+ TAMs compared with NSGCTs (P < .05). Activated TILs are increased in NM-seminomas compared with M-seminomas (P < .05). All GCTs retained MMR expression.
CONCLUSIONS: Robust PD-L1+ TAMs are significantly expanded in seminomas compared with NSGCTs. Among all GCTs, only choriocarcinoma cells reveal true positivity for PD-L1. These findings expand the realm of potentially targeted treatments for GCTs. © American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Immune microenvironment; PD-L1; Testicular germ cell tumors

Mesh:

Substances:

Year:  2020        PMID: 31802108     DOI: 10.1093/ajcp/aqz184

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Mismatch repair deficiency occurs very rarely in seminomas.

Authors:  David Dum; Stefan Steurer; Ronald Simon; Pia Victoria Zimmermann; Eike Burandt; Till Sebastian Clauditz; Margit Fisch; Michael Rink; Roland Dahlem; Wolfgang Höppner; Henrik Zecha; Ousman Doh; Cord Matthies; Waldemar Wilczak; Guido Sauter; Christoph Fraune
Journal:  Transl Androl Urol       Date:  2021-03

2.  Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours.

Authors:  Tim Nestler; Priya Dalvi; Friederike Haidl; Maike Wittersheim; Melanie von Brandenstein; Pia Paffenholz; Svenja Wagener-Ryczek; David Pfister; Ulrike Koitzsch; Martin Hellmich; Reinhard Buettner; Margarete Odenthal; Axel Heidenreich
Journal:  Br J Cancer       Date:  2022-01-12       Impact factor: 9.075

Review 3.  Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer.

Authors:  Sara Bleve; Maria Concetta Cursano; Chiara Casadei; Giuseppe Schepisi; Cecilia Menna; Milena Urbini; Caterina Gianni; Silvia De Padova; Alessia Filograna; Valentina Gallà; Giovanni Rosti; Domenico Barone; Michal Chovanec; Michal Mego; Ugo De Giorgi
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

4.  Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level.

Authors:  Margaretha A Skowron; Katharina Eul; Alexa Stephan; Gillian F Ludwig; Gamal A Wakileh; Arthur Bister; Christian Söhngen; Katharina Raba; Patrick Petzsch; Gereon Poschmann; Edmund Osei Kuffour; Daniel Degrandi; Shafaqat Ali; Constanze Wiek; Helmut Hanenberg; Carsten Münk; Kai Stühler; Karl Köhrer; Elvira Mass; Daniel Nettersheim
Journal:  Mol Oncol       Date:  2022-07-26       Impact factor: 7.449

5.  Three-gene prognostic biomarkers for seminoma identified by weighted gene co-expression network analysis.

Authors:  Hualin Chen; Gang Chen; Yang Pan; Xiaoxiang Jin
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.